Seegene's saliva test for COVID-19 is just as effective as NPS test
SEOUL, South Korea, Feb.18, 2021 /PRNewswire/ -- A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen. A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine,...
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants
* SEEGENE ROLLS OUT FIRST COVID-19 MUTANT IDENTIFICATION TEST * COVID-19 TEST MANUFACTURER CONTINUES TRACKING VARIANTS * S. KOREAN FIRM COMMITTED TO WORKING WITH GOVERNMENTS SEOUL, South Korea, Feb. 1, 2021 /PRNewswire/ -- South Korea's biotechnology firm Seegene (KQ096530) said Monday it ...
Seegene to advance business in Latin America in the New Year
SEOUL, South Korea, Jan. 21, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm Seegene Inc. (KQ096530) said Wednesday that it is expanding its business inLatin America in the new year with a strong focus on its multiplex assay product. Seegene said it received an approval f...
Seegene's COVID-19 test with saliva sample collection feature now available in Europe
SEOUL, South Korea, Jan. 6, 2021 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Tuesday that it has CE-IVD marked the saliva-based testing application for Allplex™ SARS-CoV-2 Assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay...
Seegene's COVID-19 test with saliva sample collection feature now available in Europe
SEOUL, South Korea, Jan. 6, 2021 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Tuesday that it has CE-IVD marked the saliva-based testing application for Allplex™ SARS-CoV-2 Assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay...
Seegene donates 20,000 COVID-19 tests to Ecuador
SEOUL, South Korea, Dec. 17, 2020 /PRNewswire/ -- Seegene Inc. (KQ096530), a South Korean biotechnology company specializing in molecular diagnostics says it has donated 20,000 COVID-19 tests (Allplex™ SARS-CoV-2 Assay) to Ecuadorian government to help fight the COVID-19 pandemic together. The So...
Seegene's aggregated sales surpass KRW 1 tril. this year and plans on expanding annual production capacity to KRW 5 tril. in 2021
SEOUL, South Korea, Dec. 13, 2020 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnosis, Seegene Inc. (KQ096530), announced Monday that its aggregated sales this year have already surpassed theKRW 1 trillion mark, up nearly 10 times its previous annual sales of K...
Seegene's COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe
SEOUL, South Korea, Dec. 3, 2020 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Thursday that the extraction-free application of Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay is now available inEurope. Previously in September, Se...
Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls
SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ -- Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A, Flu B, RSV A/B, and three different target genes of COVID-19 (S gene, RdRP gene and N ge...
Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls
SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ -- Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A, Flu B, RSV A/B, and three different target genes of COVID-19 (S gene, RdRP gene and N ge...
Seegene Allplex(TM) 2019-nCoV Assay (SARS-CoV-2) Gets Expanded FDA Emergency Use Authorization
SEOUL, South Korea, July 30, 2020 /PRNewswire/ -- Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) has further expanded the emergency use authorization (EUA) for its Allplex™ 2019-nCoV Assay, a real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COV...
Seegene Exports 10 million Corona Tests to Brazil
SEOUL, Korea, May 18, 2020 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered inSouth Korea, announced that it will export 10 million tests of its COVID-19 testing kits to Pan American Health Organization (PAHO) / World Health Organization (W...
Seegene's Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization
SEOUL, South Korea, April 22, 2020 /PRNewswire/ -- Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVID-19 disease. ...
Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries
SEOUL, South Korea, April 20, 2020 /PRNewswire/ -- Seegene, Inc., the leading multiplex diagnostic assay developer, today announced that the company has exported over 10 million tests of Allplex™ 2019-nCoV Assay to over 60 countries, which accounts for a significant portion of globally performed ...
Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries
SEOUL, South Korea, April 20, 2020 /PRNewswire/ -- Seegene, Inc., the leading multiplex diagnostic assay developer, today announced that the company has exported over 10 million tests of Allplex™ 2019-nCoV Assay to over 60 countries, which accounts for a significant portion of globally performed ...
Seegene Receives Health Canada Approval for its COVID-19 Assay
SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- Seegene, Inc. announced that Health Canada (HC) authorized an interim order which allows the import and sale inCanada of Seegene's Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVI...
Seegene launches KFDA Approved COVID-19 Assay
SEOUL, South Korea, Feb. 18, 2020 /PRNewswire/ -- Korea Centers for Disease Control & Prevention notified Seegene Inc. (096530.KQ) that Korea Ministry of Food and Drug Safety (MFDS; Former KFDA) approved its novel coronavirus (COIVD-19) Real-time PCR assay for the Emergency Use, following the rec...
Seegene Highlights Clinical Automated Nucleic Acid Extraction System at ASM Microbe 2019
SEOUL, South Korea, June 21, 2019 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered inSouth Korea, announced that it has completed the FDA registration of its nucleic acid extraction instrument, the Seegene STARlet, and will begin offering t...
Seegene Establishes Brazilian Subsidiary
SEOUL, South Korea, June 18, 2019 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered inSouth Korea, announced today the formation of a new subsidiary, Seegene do Brasil Diagnosticos Ltda., inBelo Horizonte, Brazil. Seegene do Brasil Diagnos...
Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method
SEOUL, South Korea, Nov. 26, 2018 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR assays, announced that multi-site clinical trials for measuring clinical performance on screening the drug resistance of Enterobacteriaceae with the Allplex™ Entero-DR assay have been ...
